During the past decade, Arthritis Group conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 17 clinical trials were completed, i.e. on average, 170% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 12 clinical trials were completed. i.e. 1200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arthritis Group" #1 sponsor was "Pfizer" with 6 trials, followed by "Hoffmann-La Roche" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored, "Bristol-Myers Squibb" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arthritis Group" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Biogen" with 1 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Arthritis Group" are "Rheumatoid Arthritis" (14 trials), "Osteoarthritis, Hip" (2 trials), "Osteoarthritis, Knee" (2 trials), "Arthritis, Psoriatic" (1 trials) and "Arthritis, Rheumatoid" (1 trials). Many other conditions were trialed in "Arthritis Group" in a lesser frequency.

Most popular intervention types in "Arthritis Group" are "Drug" (19 trials), "Biological" (5 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Filgotinib" (2 trials), "Methotrexate" (2 trials), "Placebo to match filgotinib" (2 trials) and "Tanezumab 2.5 mg" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arthritis Group" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Arthritis Group". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 18 completed trials in Arthritis Group, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Arthritis Group, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 2 trials that are defined as “Not Applicable".